BR9916214A - Dispositivos de distribuição de nicotina transdérmicos transparentes - Google Patents

Dispositivos de distribuição de nicotina transdérmicos transparentes

Info

Publication number
BR9916214A
BR9916214A BR9916214-8A BR9916214A BR9916214A BR 9916214 A BR9916214 A BR 9916214A BR 9916214 A BR9916214 A BR 9916214A BR 9916214 A BR9916214 A BR 9916214A
Authority
BR
Brazil
Prior art keywords
delivery devices
nicotine delivery
transdermal nicotine
transparent
transparent transdermal
Prior art date
Application number
BR9916214-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert M Gale
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27381223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9916214(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of BR9916214A publication Critical patent/BR9916214A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9916214-8A 1998-12-18 1999-12-14 Dispositivos de distribuição de nicotina transdérmicos transparentes BR9916214A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11273098P 1998-12-18 1998-12-18
US12467999P 1999-03-16 1999-03-16
US12679899P 1999-03-30 1999-03-30
PCT/US1999/029731 WO2000037058A1 (en) 1998-12-18 1999-12-14 Transparent transdermal nicotine delivery devices

Publications (1)

Publication Number Publication Date
BR9916214A true BR9916214A (pt) 2001-09-11

Family

ID=27381223

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916214-8A BR9916214A (pt) 1998-12-18 1999-12-14 Dispositivos de distribuição de nicotina transdérmicos transparentes

Country Status (23)

Country Link
US (6) US7622136B2 (https=)
EP (2) EP2158903A3 (https=)
JP (1) JP4864204B2 (https=)
KR (1) KR100603168B1 (https=)
CN (2) CN1331586A (https=)
AT (1) ATE447398T1 (https=)
AU (1) AU774594B2 (https=)
BR (1) BR9916214A (https=)
CA (1) CA2354621C (https=)
CY (1) CY1110643T1 (https=)
CZ (1) CZ302035B6 (https=)
DE (1) DE69941629D1 (https=)
DK (1) DK1140039T3 (https=)
ES (1) ES2336054T3 (https=)
HK (1) HK1040915B (https=)
HU (1) HUP0104728A3 (https=)
IL (2) IL143778A0 (https=)
NO (1) NO332084B1 (https=)
NZ (1) NZ512432A (https=)
PL (1) PL195871B1 (https=)
PT (1) PT1140039E (https=)
TR (1) TR200101783T2 (https=)
WO (1) WO2000037058A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985304A (en) 1998-02-25 1999-11-16 Battelle Memorial Institute Barrier preventing wood pest access to wooden structures
ES2336054T3 (es) 1998-12-18 2010-04-07 Alza Corporation Dispositivo transparente para la administracion transdermica de nicotina.
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
DE10317692A1 (de) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) † 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
US8383149B2 (en) 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
EP1774964B1 (en) 2005-10-13 2014-08-06 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
DE102010053792A1 (de) 2010-12-08 2012-06-14 Frank Becher Flächiges wirkstoffhaltiges System zur Entkeimung von Kontaktflächen
DE102011080390B3 (de) * 2011-08-03 2012-07-12 Acino Ag Applikationshilfe
GB2503939A (en) * 2012-07-13 2014-01-15 Kind Consumer Ltd Products derived from tobaccco biomass
US20150157509A1 (en) * 2013-12-11 2015-06-11 Oscar Polk Atkinson Occlusive skin covering
DE102017104026A1 (de) * 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
WO2019119292A1 (zh) * 2017-12-20 2019-06-27 沃康生技股份有限公司 一种贴覆结构
US20220160647A1 (en) * 2020-11-24 2022-05-26 First Necessity, LLC Transdermal drug delivery device/transdermal patch and other applications of emulsion formulation

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US498062A (en) * 1893-05-23 Method of converting iron into steel
US645502A (en) * 1898-10-28 1900-03-13 Lewis A Carpenter Repair-plug for pneumatic tires.
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE2644323C3 (de) * 1976-10-01 1980-03-20 Metallgesellschaft Ag, 6000 Frankfurt Verfahren zum Regenerieren von wasserhaltigen leichtflüchtigen organischen Lösungsmitteln, die zum Auswaschen saurer Gasbestandteile aus wasserarmen Gasen mit geringen Gehalten an flüchtigen Verbindungen von Metallen der 8. Gruppe eingesetzt werden
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5522535A (en) * 1978-08-04 1980-02-18 Bridgestone Corp Heavy vehicle pneumatic tire
US4203440A (en) 1978-10-23 1980-05-20 Alza Corporation Device having variable volume chamber for dispensing useful agent
JPS5632414A (en) * 1979-08-28 1981-04-01 Suzuki Nihondou:Kk Preparation of stretchable clear sticking plaster
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS6244654Y2 (https=) * 1981-04-11 1987-11-26
US4849226A (en) 1981-06-29 1989-07-18 Alza Corporation Method for increasing oxygen supply by administering vasodilator
US4725272A (en) 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
US4373454A (en) * 1981-08-28 1983-02-15 The United States Of America As Represented By The Department Of Energy Oil shale retorting and combustion system
US4435180A (en) 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
US4559222A (en) 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
JPS6069014A (ja) 1983-09-27 1985-04-19 Nitto Electric Ind Co Ltd 皮膚疾患治療用貼付剤
AU591171B2 (en) 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US4627850A (en) 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4704282A (en) 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
DE3586707T2 (de) 1984-10-05 1993-02-11 Hercon Lab System zur transdermalen applikation eines arzneimittels.
US4568343A (en) 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4573995A (en) 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
DE3586713T2 (de) 1984-11-15 1993-05-13 Hercon Lab Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US5016652A (en) 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4904475A (en) 1985-05-03 1990-02-27 Alza Corporation Transdermal delivery of drugs from an aqueous reservoir
US4645502A (en) 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4698062A (en) 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4710191A (en) 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US5316759A (en) 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
DE3775830D1 (de) 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US5344656A (en) 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4816258A (en) 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4788062A (en) 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5071656A (en) 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
DE3743947A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4839174A (en) 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US4917895A (en) 1987-11-02 1990-04-17 Alza Corporation Transdermal drug delivery device
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4915895A (en) * 1987-11-30 1990-04-10 General Motors Corporation Method for making a composite tread for track-laying vehicles
US4915950A (en) 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US4840796A (en) 1988-04-22 1989-06-20 Dow Corning Corporation Block copolymer matrix for transdermal drug release
US5364630A (en) * 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5167649A (en) * 1988-08-22 1992-12-01 Zook Gerald P Drug delivery system for the removal of dermal lesions
US4908213A (en) 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
US5230896A (en) 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
US5077104A (en) 1989-12-21 1991-12-31 Alza Corporation Nicotine packaging materials
SE8904296D0 (sv) 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5122382A (en) 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5314694A (en) 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
JP3067114B2 (ja) * 1991-06-04 2000-07-17 ソニー株式会社 マイクロレンズ形成方法
JPH0523925A (ja) 1991-07-19 1993-02-02 Mazda Motor Corp 部品組付装置におけるフローテイング支持機構
US6010715A (en) * 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
ZA933349B (en) 1992-05-13 1994-06-15 Alza Corp Transdermal administration of oxybutynin
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
WO1995001766A1 (en) 1993-07-09 1995-01-19 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
JPH07165563A (ja) * 1993-12-08 1995-06-27 Sekisui Chem Co Ltd テープ製剤
JP3021661B2 (ja) * 1994-03-07 2000-03-15 セラテック・インコーポレーテッド 薬剤含有接着複合体の経皮放出デバイス
WO1996000072A1 (en) 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
WO1997033581A1 (en) 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds
CA2250025C (en) 1996-03-25 2006-10-31 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
JPH09323925A (ja) * 1996-06-03 1997-12-16 Sekisui Chem Co Ltd 貼付剤
GR1002807B (el) * 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
IT1289160B1 (it) 1997-01-08 1998-09-29 Jagotec Ag Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
JPH10279472A (ja) * 1997-04-02 1998-10-20 Oji Paper Co Ltd 外用貼付剤
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6013722A (en) 1998-01-27 2000-01-11 3M Innovative Properties Company Non-whitening emulsion pressure sensitive adhesives
FR2778560B1 (fr) * 1998-05-12 2001-06-01 Oreal Utilisation de l'acide cinnamique ou d'au moins l'un de ses derives dans une composition destinee a favoriser la desquamation de la peau, et composition le comprenant
ES2336054T3 (es) 1998-12-18 2010-04-07 Alza Corporation Dispositivo transparente para la administracion transdermica de nicotina.
CN102736278B (zh) 2011-04-01 2014-12-17 纬创资通股份有限公司 液晶显示装置及具有该液晶显示装置的电子设备

Also Published As

Publication number Publication date
US20140180223A1 (en) 2014-06-26
WO2000037058A1 (en) 2000-06-29
US8999379B2 (en) 2015-04-07
US20080031933A1 (en) 2008-02-07
HK1040915A1 (en) 2002-06-28
HUP0104728A2 (hu) 2002-05-29
DK1140039T3 (da) 2010-03-22
NO20013012L (no) 2001-06-18
IL143778A (en) 2008-03-20
US20040234585A1 (en) 2004-11-25
US8663680B2 (en) 2014-03-04
CA2354621A1 (en) 2000-06-29
US20120310187A1 (en) 2012-12-06
NZ512432A (en) 2003-10-31
KR20010084881A (ko) 2001-09-06
JP2002532540A (ja) 2002-10-02
US7622136B2 (en) 2009-11-24
US20150164820A1 (en) 2015-06-18
EP2158903A3 (en) 2010-04-14
NO20013012D0 (no) 2001-06-18
US20160058747A1 (en) 2016-03-03
HUP0104728A3 (en) 2006-07-28
AU3121700A (en) 2000-07-12
PL348337A1 (en) 2002-05-20
JP4864204B2 (ja) 2012-02-01
CZ302035B6 (cs) 2010-09-15
ES2336054T3 (es) 2010-04-07
HK1040915B (en) 2010-05-07
CZ20012230A3 (cs) 2001-10-17
EP2158903A2 (en) 2010-03-03
EP1140039A1 (en) 2001-10-10
CN1331586A (zh) 2002-01-16
EP1140039B1 (en) 2009-11-04
US8075911B2 (en) 2011-12-13
NO332084B1 (no) 2012-06-18
CN101693023A (zh) 2010-04-14
PT1140039E (pt) 2010-02-03
IL143778A0 (en) 2002-04-21
KR100603168B1 (ko) 2006-07-24
ATE447398T1 (de) 2009-11-15
AU774594B2 (en) 2004-07-01
PL195871B1 (pl) 2007-11-30
CA2354621C (en) 2009-09-29
DE69941629D1 (de) 2009-12-17
US9205059B2 (en) 2015-12-08
CY1110643T1 (el) 2015-04-29
TR200101783T2 (tr) 2002-05-21

Similar Documents

Publication Publication Date Title
BR9916214A (pt) Dispositivos de distribuição de nicotina transdérmicos transparentes
BR0106967A (pt) Dispositivo de acondicionamento e/ou de aplicação que contém fibras que possuem pelo menos um corpo imantado ou imantável
BR9917089A (pt) Composições e métodos para distribuição mucosal
DE69935154D1 (de) Inhalationssystem
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
AR019690A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
AR016217A1 (es) Composicion farmaceutica que comprende un modulador dispositivo de un agonista receptor nicotinico, metodo para el tratamiento de un trastorno asociado conuna transmision reducida de nicotina, metodo para identificar un agonista repector nicotinico, uso de un modulador positivo de un agonista recept
BR9712491A (pt) Composições cosméticas
AU2003279705A8 (en) Vaporiser
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
BR0116087A (pt) Fio dental e fita dental revestidos com hemostato e método de feitura dos mesmos
PT941085E (pt) Dispositivo para administracao electricamente assistida de agentes como a lidocaina e a epinefrina
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
BR0207654A (pt) Composição que compreende um creme ou loção base
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
BR0212607A (pt) Agonistas retinóides ii de uréia substituìda
ATE227997T1 (de) Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid
BR9907195A (pt) " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
NO20012169L (no) Forbindelser med veksthormonfrigjörende egenskaper
BR9910465A (pt) Uso de um agente que mantém ou melhora a barreira de permeabilidade da gengiva

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 9/70, A61K 31/465, A61P 25/34

Ipc: A61K 9/70 (2008.04), A61K 31/465 (2008.04), A61P 2

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MEMSO NAO ATENDE AO DISPOSTO NOS ARTIGOS 8O, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]